CA2906389A1 - Solution therapeutique liquide exempte de colorant - Google Patents

Solution therapeutique liquide exempte de colorant

Info

Publication number
CA2906389A1
CA2906389A1 CA2906389A CA2906389A CA2906389A1 CA 2906389 A1 CA2906389 A1 CA 2906389A1 CA 2906389 A CA2906389 A CA 2906389A CA 2906389 A CA2906389 A CA 2906389A CA 2906389 A1 CA2906389 A1 CA 2906389A1
Authority
CA
Canada
Prior art keywords
liquid composition
weight
composition
liquid
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2906389A
Other languages
English (en)
Inventor
Mahesh Sudhakar Bharati
Houphouet Hyacinthe Yarabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Healthcare Pvt Ltd
Novartis Consumer Health Inc
Original Assignee
Novartis Healthcare Pvt Ltd
Novartis Consumer Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Healthcare Pvt Ltd, Novartis Consumer Health Inc filed Critical Novartis Healthcare Pvt Ltd
Priority claimed from PCT/US2014/021590 external-priority patent/WO2014149939A1/fr
Publication of CA2906389A1 publication Critical patent/CA2906389A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2906389A 2013-03-15 2014-03-07 Solution therapeutique liquide exempte de colorant Abandoned CA2906389A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN765DE2013 2013-03-15
IN765/DEL/2013 2013-03-15
PCT/US2014/021590 WO2014149939A1 (fr) 2013-03-15 2014-03-07 Solution thérapeutique liquide exempte de colorant

Publications (1)

Publication Number Publication Date
CA2906389A1 true CA2906389A1 (fr) 2014-09-25

Family

ID=54258944

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2906389A Abandoned CA2906389A1 (fr) 2013-03-15 2014-03-07 Solution therapeutique liquide exempte de colorant

Country Status (4)

Country Link
EP (1) EP2968573A1 (fr)
CN (1) CN105263524A (fr)
CA (1) CA2906389A1 (fr)
SG (1) SG11201507369WA (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110115708A (zh) * 2018-02-07 2019-08-13 保瑞药业股份有限公司 乙酰胺酚及曲马多共溶复方止痛口服液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
MXPA04003789A (es) * 2001-10-22 2005-06-03 Taro Pharma Ind Formulacion resistente al derrame enmascarante de degustacion.
US20080085892A1 (en) * 2006-08-31 2008-04-10 Sangeetha Kandeepan Liquid dosage form of acetaminophen

Also Published As

Publication number Publication date
CN105263524A (zh) 2016-01-20
SG11201507369WA (en) 2015-10-29
EP2968573A1 (fr) 2016-01-20

Similar Documents

Publication Publication Date Title
CA2333528C (fr) Sirop a antihistamines stabilise contenant un stabilisant acide aminopolycarboxylique
HU230456B1 (hu) Aripiprazol orális oldatai
EP1067934B1 (fr) Solution orale liquide contenant l'antidepresseur mirtazapine
AU2012367017B2 (en) Medicament delivery technology
US20140275151A1 (en) Dye free liquid therapeutic solution
JP4959335B2 (ja) メチルフェニデート溶液および関連する投与および製造方法
CA2906389A1 (fr) Solution therapeutique liquide exempte de colorant
US8518439B2 (en) Liquid therapeutic composition
US11771706B2 (en) Oral solutions comprising fludrocortisone acetate
KR20200111138A (ko) 용해성 및 안정성이 향상된 덱시부프로펜 시럽제제
US20210213024A1 (en) Liquid compositions of aprepitant
US7632853B2 (en) Soluble, stable and concentrated pharmaceutical composition compromising ritonavir and process for preparing thereof
US20060217320A1 (en) Soft gel formulations for saquinavir
EP4382093A1 (fr) Suspensions orales comprenant de la capécitabine
EP4279062A1 (fr) Composition liquide et son utilisation, procédé de traitement et kit
CN114828829A (zh) 包含布洛芬和去氧肾上腺素的液体组合物
MXPA00009677A (en) Oral liquid antidepressant solution
MXPA00011834A (en) A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190307